Adjunctive antidepressant treatment for bipolar depression [3]

New England Journal of Medicine

Volumn 357, Issue 6, 2007, Pages 615-

  El Mallakh, Rif S ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CARBAMAZEPINE; LAMOTRIGINE; LITHIUM; VALPROIC ACID; TRANQUILIZER;

BIPOLAR DEPRESSION; DRUG EFFECT; HUMAN; LETTER; METHODOLOGY; PRIORITY JOURNAL; BIPOLAR DISORDER; DRUG ANTAGONISM; DRUG COMBINATION; NOTE;

ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIMANIC AGENTS; BIPOLAR DISORDER; DRUG ANTAGONISM; DRUG THERAPY, COMBINATION; HUMANS;

EID: 34547727225     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Nemeroff CB, Evans DL, Gyulai L, et al. Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry 2001;158:906-12.
2. Post RM, Leverich GS, Nolen WA, et al. A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network. Bipolar Disord 2003;5:396-406.
3. Amsterdam J. Efficacy and safety of venlafaxine in treatment of bipolar II major depressive episode. J Clin Psychopharmacol 1998;18:414-7.
4. Amsterdam JD, Garcia-España F, Fawcett J, et al. Efficacy and safety of fluoxetine in treating bipolar II major depressive episode. J Clin Psychopharmacol 1998;18:435-40.
5. Tohen M, Vieta E, Calabrese J, et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry 2003;60:1079-88. [Erratum, Arch Gen Psychiatry 2004;61:176.]